TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05243966: Myriad™ Augmented Soft Tissue Reconstruction Registry

Sponsor: Aroa Biosurgery Limited · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 800 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT05243966 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05243966 Rescue Dossier →